CHARIFSON, PAUL S.,CLARK, MICHAEL P.,BANDARAGE, UPUL K.,BETHIEL, RANDY S.,BOYD, MICHAEL J.,DAVIES, IOANA,DENG, HONGBO,DUFFY, JOHN P.,FARMER, LUC J.,GAO, HUAI,GU, WENXIN,KENNEDY, JOSEPH M.,LEDFORD, BRI
申请号:
RSP20170273
公开号:
RS55858B1
申请日:
2012.08.01
申请国别(地区):
RS
年份:
2017
代理人:
摘要:
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula ( I ): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( I ) are as described herein. A compound is represented by Structural Formula ( I ) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( I ) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.